Global Gene Expression Assay Service Market Growth (Status and Outlook) 2025-2031

The global Gene Expression Assay Service market size is predicted to grow from US$ 625 million in 2025 to US$ 857 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

Gene expression assay services are used to measure the activity of specific genes by detecting and quantifying the mRNA transcripts produced by those genes. These services help researchers study gene regulation, biomarker discovery, disease mechanisms, and other cellular processes.

United States market for Gene Expression Assay Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Gene Expression Assay Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Gene Expression Assay Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Gene Expression Assay Service players cover Applied Biological Materials Inc. (abm), Thermo Fisher Scientific, Lexogen, Avance Biosciences, Charles River, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Gene Expression Assay Service Industry Forecast” looks at past sales and reviews total world Gene Expression Assay Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Expression Assay Service sales for 2025 through 2031. With Gene Expression Assay Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Expression Assay Service industry.

This Insight Report provides a comprehensive analysis of the global Gene Expression Assay Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Expression Assay Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Expression Assay Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Expression Assay Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Expression Assay Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Expression Assay Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Real-time qPCR
Digital PCR
RNA-Seq

Segmentation by Application:
Basic Biological Research
Disease Diagnosis and Treatment
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Applied Biological Materials Inc. (abm)
Thermo Fisher Scientific
Lexogen
Avance Biosciences
Charles River
Inotiv
Bio-Rad
Fios Genomics
Creative Biolabs
Labcorp
INDIGO
Epistem
Discovery Life Sciences
Molecular Genomics

Please note: The report will take approximately 2 business days to prepare and deliver.